Vax Before Cancer

 / May 9th, 2021

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

May 8 • 12:59 pm CDT
A global biotechnology company announced that its PARP inhibitor pamiparib had received conditional approval from the China National Medical Products Administration (NMPA) for the treatment of patients with germline BRCA (gBRCA) mutation-associated recurrent advanced ovarian, fallopian...
May 7 • 4:57 am CDT
Bellevue-based Viome announced its proprietary mRNA analysis technology combined with its next-generation AI platform had been designated a Breakthrough Device by the Food and Drug Administration (FDA) for early detection of oral cancer and throat cancer...
May 6 • 1:41 pm CDT
Basel-based Roche announced on May 5, 2021, that the European Commission has approved Tecentriq® (atezolizumab) as a first-line treatment for adults with metastatic non-small cell lung cancer whose tumors have high PD-L1 expression, with no epidermal...
May 5 • 10:57 am CDT
A clinical-stage immunotherapy company based in The Netherlands dedicated to developing immunotherapeutics for oncology and infectious diseases announced the publication in Nature Reviews Cancer on May 4, 2021, a review of therapeutic cancer vaccines. The Nature...
May 3 • 8:16 pm CDT
Vancouver-based BioVaxys Technology Corp. announced today that it had signed the definitive exclusive bioproduction agreement with BioElpida S.A.S. of Lyon, France, to begin the clinical-grade bioproduction and aseptic packaging for BXV-0918A, BioVaxys' vaccine candidate for Stage...

For more articles, try our search.